Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nuria Arias-Ramos"'
Publikováno v:
Brain Sciences, Vol 14, Iss 6, p 526 (2024)
Brain tumors are a significant concern for the global medical community, with over 300,000 cases reported annually worldwide [...]
Externí odkaz:
https://doaj.org/article/fbce0bbe9d6b436f8534171e005aff5c
Publikováno v:
Brain Sciences, Vol 14, Iss 5, p 409 (2024)
Glioblastoma (GBM) stands as the most prevalent and lethal malignant brain tumor, characterized by its highly infiltrative nature. This study aimed to identify additional MRI and metabolomic biomarkers of GBM and its impact on healthy tissue using an
Externí odkaz:
https://doaj.org/article/ef640b60f34c488f9022cc01e1698e63
Autor:
Nuria Arias-Ramos, Luis Exequiel Ibarra, María Serrano-Torres, Balbino Yagüe, Matías Daniel Caverzán, Carlos Alberto Chesta, Rodrigo Emiliano Palacios, Pilar López-Larrubia
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1258 (2021)
Conjugated polymer nanoparticles (CPNs) have emerged as advanced polymeric nanoplatforms in biomedical applications by virtue of extraordinary properties including high fluorescence brightness, large absorption coefficients of one and two-photons, an
Externí odkaz:
https://doaj.org/article/348571f5d5b241ab83fdca4ac0f81c58
Autor:
Nuria Arias-Ramos, Laura Ferrer-Font, Silvia Lope-Piedrafita, Victor Mocioiu, Margarida Julià-Sapé, Martí Pumarola, Carles Arús, Ana Paula Candiota
Publikováno v:
Metabolites, Vol 7, Iss 2, p 20 (2017)
Glioblastoma (GBM) is the most common aggressive primary brain tumor in adults, with a short survival time even after aggressive therapy. Non-invasive surrogate biomarkers of therapy response may be relevant for improving patient survival. Previous w
Externí odkaz:
https://doaj.org/article/5e19de8bad1045ad974b2bedaa66423d
Autor:
Laura Ferrer-Font, Lucia Villamañan, Nuria Arias-Ramos, Jordi Vilardell, Maria Plana, Maria Ruzzene, Lorenzo A. Pinna, Emilio Itarte, Carles Arús, Ana Paula Candiota
Publikováno v:
Pharmaceuticals, Vol 10, Iss 1, p 24 (2017)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development
Externí odkaz:
https://doaj.org/article/e670bbaecb9a42958d9d85d51579d85e
Autor:
María Serrano-Torres, Luis Exequiel Ibarra, Matías Daniel Caverzán, Balbino Yagüe, Nuria Arias-Ramos, Rodrigo E. Palacios, Pilar López-Larrubia, Carlos A. Chesta
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Pharmaceutics, Vol 13, Iss 1258, p 1258 (2021)
Pharmaceutics
Volume 13
Issue 8
instname
Pharmaceutics, Vol 13, Iss 1258, p 1258 (2021)
Pharmaceutics
Volume 13
Issue 8
© 2021 by the authors.
Conjugated polymer nanoparticles (CPNs) have emerged as advanced polymeric nanoplatforms in biomedical applications by virtue of extraordinary properties including high fluorescence brightness, large absorption coefficien
Conjugated polymer nanoparticles (CPNs) have emerged as advanced polymeric nanoplatforms in biomedical applications by virtue of extraordinary properties including high fluorescence brightness, large absorption coefficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c3a9954e9dcc722bf16468678e92ad
http://hdl.handle.net/10261/265215
http://hdl.handle.net/10261/265215
Autor:
Pilar López-Larrubia, Lucía Beaugé, Rodrigo E. Palacios, Viviana Rivarola, Luis Exequiel Ibarra, Carlos A. Chesta, Nuria Arias-Ramos
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Aim]: To assess monocyte-based delivery of conjugated polymer nanoparticles (CPNs) for improved photodynamic therapy (PDT) in glioblastoma (GBM).
[Materials and methods]: Human monocyte cells (THP-1) and murine monocytes isolated from bone marr
[Materials and methods]: Human monocyte cells (THP-1) and murine monocytes isolated from bone marr
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The pharmacological action of the V(IV) compound VO(dmpp)2 was previously evaluated in vivo using obese pre-diabetic Zucker rats treated with this compound for four weeks. Besides the promising results regarding biological parameters indicative of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef58d0d5eb4384124d7cabcb73c0fda
http://hdl.handle.net/10261/207031
http://hdl.handle.net/10261/207031
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
© 2019 by the authors.
Despite important advances in multimodal therapeutic options, glioblastoma (GBM), the most frequent and aggressive form of all astrocytomas, remains with a median overall survival period of 15 months. A direct correlation
Despite important advances in multimodal therapeutic options, glioblastoma (GBM), the most frequent and aggressive form of all astrocytomas, remains with a median overall survival period of 15 months. A direct correlation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5a16cae48ff704e1169d33ac15ec9f
http://hdl.handle.net/10261/206981
http://hdl.handle.net/10261/206981
Autor:
Heling, Zhou, Nuria, Arias-Ramos, Pilar, López-Larrubia, Ralph P, Mason, Sebastián, Cerdán, Jesús, Pacheco-Torres
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1718
Oxygen monitoring is a topic of exhaustive research due to its central role in many biological processes, from energy metabolism to gene regulation. The ability to monitor in vivo the physiological distribution and the dynamics of oxygen from subcell